Article

Diabetes May Be an Osteoarthritis Risk Factor

In one study, 49% of participants with diabetes had osteoarthritis compared with 26% of participants without diabetes.

Diabetic patients may be at a greater risk for hand or knee osteoarthritis, according to a study published in the January 2013 issue of Clinical Rheumatology. Although other studies have reported a higher prevalence of osteoarthritis in diabetic patients, inconsistencies have prevented researchers from making a conclusive association between diabetes and osteoarthritis.

The cross-sectional study followed 100 adult diabetic patients and 102 nondiabetic patients in a Hispanic population from Puerto Rico. Osteoarthritis of hand and knee was diagnosed using the American College of Rheumatology classification criteria. The researchers considered sociodemographic characteristics, comorbidities, and pharmacotherapy in their analyses.

Almost half, 49%, of diabetic participants had osteoarthritis while only 26% of nondiabetic patients were diagnosed with osteoarthritis. Researchers also found that female diabetic patients were more likely to have hand or knee osteoarthritis than male diabetic patients. Diabetic patients who did not use insulin were also at a greater risk for osteoarthritis.

This article was originally published on the Pharmacy Times website.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Viet Le, DMSc, PA-C | Credit: APAC
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.